2021
DOI: 10.22146/ijp.2236
|View full text |Cite
|
Sign up to set email alerts
|

Medication Nonadherence: Implications for patient health outcomes in pharmacy practice

Abstract: ABSTRACT Objectives: The primary objective of this review is (1) to better understand the prevalence and impact of medication nonadherence, (2) to identify risk factors for medication nonadherence, (3) to understand the association between nonadherence and its implications on patient health outcomes in pharmacy practice, and (4) to study interventions designed to improve patient adherence to prescribed medications for medical conditions, considering its impact on both medication adherence and patient hea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 52 publications
0
3
0
Order By: Relevance
“…Those could influence neuropathy through improvement in controlling blood sugar and insulin sensitivity (Zilliox & Russell, 2019). Indeed, the medication factor is an important and critical point that affects disease progression (Al-Temimi et al, 2021). Adherence to medication consumption might involve a confounding factor (da Silva et al, 2019).…”
Section: Volume 35 Issue 1 (2024)mentioning
confidence: 99%
“…Those could influence neuropathy through improvement in controlling blood sugar and insulin sensitivity (Zilliox & Russell, 2019). Indeed, the medication factor is an important and critical point that affects disease progression (Al-Temimi et al, 2021). Adherence to medication consumption might involve a confounding factor (da Silva et al, 2019).…”
Section: Volume 35 Issue 1 (2024)mentioning
confidence: 99%
“…Medication safety in the advancement stage is progressively impacted by the restrictions imposed by sponsors on the research policy, the lab program and the open sharing of data as the exploration schedule is negotiated with clinical associates [33]. There is developing public worries that nearby coordinated effort among academia and pharmaceutical manufacturers may antagonistically influence clinical practice and clinical studies [25,34,35].…”
Section: Promotional Activitiesmentioning
confidence: 99%
“…Aside from being a significant contributor to ache, it is additionally connected with diminishing physical movement and may prompt restriction of one's freedom and influence wellbeing related nature of life and furthermore prompts loss of productivity [5][6]. Ladies matured 50 years or more than knee OA can be considered among the interminable noncommunicable illnesses, and inquiries through the lifestyle and propensities (for example, from sociological points of view) can be extremely useful in distinguishing more hazard factors that are manageable for anticipation and control of this perilous issue [7][8][9][10][11][12][13][14][15].…”
Section: Introductionmentioning
confidence: 99%